2,5-Dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxylate, 95.0%, 25g

Jasmonic Acid (mixture of isomers)>85.0%(GC)1g

Hexahydrohippuric acid, 98%, 5g

1-BENZYL-5-METHYL-1,4-DIAZEPANE, 95.0%, 250mg

2-Thioxo-2,3,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4(5H)-one, 95.0%, 10g

(R)-Methyl 3-amino-2,3-dihydro-1H-indene-5-carboxylate hydrochloride, 97.0%, 250mg

Fmoc-D-tert-leucine, 99.0%, 25g

METHYL 3,5-DIHYDROXYNAPHTHALENE-2-CARBOXYLATE, 95.0%, 250mg

2-(8-Ethyl-7-fluoro-3-(methoxymethoxy)naphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

Volumetric flasks class A opaque, 250 ml, 19/26, 2 Piece(s)

2,3-Dihydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester, 98+%, 1g

N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 250mg

(E)-1-Methoxy-4-(prop-1-en-1-yl)benzene, 95.0%, 25g